Summary
Thirty-nine patients (14 non-diabetics, 8 chemical diabetics, and 17 overt diabetics) with circulating islet cell antibodies (ICA) were studied. Insulin and glucagon secretion after oral (100 g) and intravenous glucose loading (200 mg/kg bolus injection followed by an infusion of 20 mg/min over 60 min) and arginine infusion (25 g over 30 minutes) were evaluated in these patients and in non diabetic and diabetic ICA-negative controls. In the non-diabetic groups with or without ICA, insulin and glucagon responses to glucose were similar. Moreover, in ICA positive patients the response of these hormones to arginine infusion was reduced. Similar alterations in insulin and glucagon secretion were observed in the ICA positive and negative patients with chemical or overt diabetes. In particular, fasting hyperglucagonaemia and glucagon hyperresponse to arginine are associated with a lack of insulin secretion in the patients with overt diabetes. Hormonal differences between diabetics with and without ICA could not be detected.
Article PDF
Similar content being viewed by others
References
Assan, R., Tiengo, A.: Comparisons des sécrétion de glucagon dans les diabètes sucrés avec ou sans pancréatopathie organique acquise. Pathol. Biol. (Paris)21, 15–25 (1972)
Bottazzo, G.F., Christensen, A.F., Doniach, D.: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet1974 II, 1279–1282
Bottazzo, G.F., Lendrum, R.: Separate autoantibodies reacting with human pancreatic glucagon and somatostatin cells. Lancet1976 II, 873–876
Cerasi, E., Luft, R.: Insulin response to glucose infusion in diabetic and non diabetic monozygotic twin pairs. Genetic control of insulin response. Acta Endocrinol. (Kbh)55, 276–304 (1967)
Craighead, J.E.: Insulitis associated with viral infection. In: P.A. Bastenie, W. Gepts (Eds.): Immunity and Autoimmunity in Diabetes Mellitus, p. 227–233. Amsterdam: Excerpta Medica 1974
Del Prete, G. F., Tiengo, A., Bersani, G., Nosadini, R., Toffolo, A., Betterle, C., Garotti, G., Trisotto, A.: Insulin and glucagon secretion in patients with pancreatic islet-cell antibodies, p. 324. Abstracts — 5th International Congress of Endocrinology, Hamburg, July 18–24, 1976
Del Prete, G.F., Padovan, D., Erle, G., Toffolo, A., Bersani, G.: Islet cell antibodies in diabetes mellitus. Diabetes (in press)
Fajans, S.S., Conn, J.S.: The early recognition of human diabetes mellitus. Ann. N. Y. Acad. Sci.82, 208 (1959)
Faloona, G.R., Unger, R.H.: Glucagon. In: B.M. Jaffe, H.R. Behrmann (Eds.): Methods of Hormone Radioimmunoassay, p. 317–330. New York, London: Academic Press 1974
Herbert, V., Kam-Seng, L., Gottlieb, C.W., Bleicher, J.: Coated charcoal immunoassay of insulin. J. Clin. Endocrinol.25, 1375–1384 (1965)
Huggett, A., Nixon, D.A.: Use of glucose oxidase, peroxidase and O-dianisidine in the determination of blood and urine glucose. Lancet1957 II, 368–370
Irvine, W.J., Clarke, B.F., Scarth, L., Cullen, D.R., Duncan, L.J.P.: Thyroid and gastric autoimmunity in patients with diabetes mellitus. Lancet1970 II, 163–168
Irvine, W.J., Gray, R.S., McCallum, C.J., Campbell, C.J., Duncan, L.J.P., Farquhar, J.W., Morris, P.J.: The prevalence of serum pancreatic islet cell antibodies in diabetes mellitus according to age at onset, insulin dependence and duration of diabetes and HL-A type, p. 221. Abstracts — 5th International Congress of Endocrinology, Hamburg, July 18–24, 1976
Irvine, W.J., Gray, R.S., McCallum, C.J.: Pancreatic isletcell antibody as a marker for asymptomatic and latent diabetes and prediabetes. Lancet1976 II, 1097–1102
Katsilambros, N., Rahman, Y.A., Hinz, M., Fussgänger, R., Schröder, K.E., Straub, K., Pfeiffer, E.F.: Action of streptozotocin on insulin and glucagon responses of rat islet. Horm. Metab. Res.2, 268–270 (1970)
Lendrum, R., Walker, G., Gamble, D.R.: Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lancet1975 I, 880–883
MacCuish, A.C., Barnes, E.W., Irvine, W.J., Duncan, L.J.P.: Antibodies to pancreatic islet cells in insulin dependent diabetics with coexistent autoimmune disease. Lancet1974 II, 1529–1531
Müller, W.A., Faloona, G.R., Aguilar-Parada, E., Unger, R.H.: Abnormal alpha cell function in diabetes: response to carbohydrate and protein ingestion. N. Engl. J. Med.283, 109–115 (1970)
Müller, W.A., Faloona, G.R., Unger, R.H.: The effect of experimental insulin deficiency on glucagon secretion. J. Clin. Invest.50, 1992–1999 (1971)
Nerup, J., Anderson, O.O., Bendixen, G., Egeberg, J., Gunnarson, R., Kromann, G., Poulsen, J.E.: Cell-mediated immunity in diabetes mellitus. Proc. R. Soc. Med.67, 506–513 (1974)
Nerup, J.: The clinical and immunological association of diabetes mellitus and Addison's Disease. In: P.A. Bastenie, W. Gepts (Eds.): Immunity and Autoimmunity in Diabetes Mellitus, p. 149. Amsterdam: Excerpta Medica 1974
Nolan, S., Stephan, T., Khurana, R.C., Morgan, C.R., Danowski, T.S.: Low profile (flat) glucose tolerances. Am. J. Med. Sci.264, 33–39 (1972)
Persson, I., Gyntelberg, F., Heding, L.G., Boss-Nielsen, J.: Pancreatic glucagon-like immunoreactivity after i. v. insulin in normals and chronic-pancreatitis patients. Acta Endocrinol. (Kbh)67, 401–408 (1971)
Roitt, I., Doniach, D.: Manual of autoimmune serology, pp. 1–8. W. H. O. (Ed.) Geneva, 1969
Ungar, B., Stocks, A.E., Martin, F.I.R., Whittingham, S., Mackay, I.R.: Intrinsic-factor antibody, parietal-cell antibody and latent pernicious anemia in diabetes mellitus. Lancet1968 II, 415–424
Unger, R.H., Aguilar-Parada, E., Müller, W., Eisentraut, A.M.: Studies of pancreatic alpha cell function in normal and diabetic subjects. J. Clin. Invest.49, 837–848 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tiengo, A., Del Prete, G.F., Nosadini, R. et al. Insulin and glucagon secretion in diabetic and non-diabetic patients with circulating islet cell antibodies. Diabetologia 13, 451–458 (1977). https://doi.org/10.1007/BF01234495
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01234495